Although these mutations were detected less frequently in comparison to PTEN and PIK3CA mutations, the detection rate of PIK3R1 mutations was similar in both tumor and cfDNA samples (only a 0.8% difference), which implies that these mutations can be reliably detected when present in GBM patients [58]. This evidence concerns the gene PTEN and neoplasm.